Satellite Symposium at the European League Against Rheumatism (EULAR) congress
Wednesday, June 13, 2018, 18:15–19:45
Auditorium, RAI Amsterdam, Amsterdam, the Netherlands
| Time | Title | Speaker |
|---|---|---|
| 18:15–18:25 | Welcome and introduction | Peter Nash, MD, FRACP Department of Medicine, University of Queensland, Brisbane, Australia |
| 18:25–18:40 | Influencing the JAK pathway: Does selective inhibition make mechanistic sense? | John Isaacs, MBBS, PhD, FRCP Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK |
| 18:40–19:00 | Beyond methotrexate: The role of JAK inhibitors when csDMARDs fail | Andrea Rubbert-Roth, MD Kantonsspital St. Gallen, St. Gallen, Switzerland |
| 19:00–19:20 | Beyond biologics: JAK inhibitors as a novel alternative in bDMARD-IR patients | Peter Nash, MD, FRACP Department of Medicine, University of Queensland, Brisbane, Australia |
| 19:20–19:45 | Panel discussion and Q&A | All |
Zinc code: NL/OTH/0318/0150e
Date of preparation: May 2018